Immunoglobulin kappa light chain and its amyloidogenic mutants: A molecular dynamics study

AL amyloidosis and LCDD are pathological conditions caused by extracellural deposition of monoclonal Ig light chain variable domains. In the former case, deposits have a form of amyloid fibrils, in the latter, amorphous aggregates. 1REI κ light chain variable domain and its two point mutants, R61N and D82I, were chosen for the analysis in this work. Wild 1REI does not create deposits in vitro, while R61N aggregates as amyloid fibrils and D82I creates amorphous aggregates. Both mutated residues create a conserved salt bridge; thus, substitution of any of them should decrease VL domain stability. For these three proteins, 5 ns MD simulations were conducted in temperatures of 300 K and 400 K, with protonated and unprotonated acidic residues, mimicking acidic and neutral experimental pH conditions (3 sets: N300, N400, and A400). The analysis of trajectories focused on characterization of changes in conformational behavior and stability of Ig κ light chain variable domain caused by single aminoacid substitutions that were experimentally proved to enhance aggregation propensity, both in the form of amyloid and amorphous aggregates. Residue D82 turns out to be involved not only in R61–D82 but also in K45–D82 interaction, which was not observed in the X‐ray structure, but frequently populated simulations of 1REI. The substitution D82I excludes both interactions, resulting in substantial destabilization (i.e., easier aggregation). Examination of behavior of edge regions of VL β‐sandwich reveals significant alterations in D82I mutant compared to wild 1REI, while relatively small changes occur in R61N. This suggests that mild and slow destabilization is the reason of the conversion of VL to partially folded amyloidogenic intermediate structure. Proteins 2004. © 2004 Wiley‐Liss, Inc.

[1]  H. Berendsen,et al.  Molecular dynamics with coupling to an external bath , 1984 .

[2]  C. Ionescu-Zanetti,et al.  Partially folded intermediates as critical precursors of light chain amyloid fibrils and amorphous aggregates. , 2001, Biochemistry.

[3]  H. Stanley,et al.  Molecular dynamics simulation of the SH3 domain aggregation suggests a generic amyloidogenesis mechanism. , 2002, Journal of molecular biology.

[4]  D. Wemmer,et al.  A glimpse of a possible amyloidogenic intermediate of transthyretin , 2000, Nature Structural Biology.

[5]  K. Olsen,et al.  Constant Region of a κ III Immunoglobulin Light Chain as a Major AL‐Amyloid Protein , 1998, Scandinavian journal of immunology.

[6]  V. Uversky,et al.  Elucidation of the Molecular Mechanism during the Early Events in Immunoglobulin Light Chain Amyloid Fibrillation , 2002, The Journal of Biological Chemistry.

[7]  H. Berendsen,et al.  Interaction Models for Water in Relation to Protein Hydration , 1981 .

[8]  S. Radford,et al.  Structural properties of an amyloid precursor of beta(2)-microglobulin. , 2002, Nature structural biology.

[9]  N. Hilschmann,et al.  Reduction of disulfide bonds in an amyloidogenic Bence Jones protein leads to formation of "amyloid-like" fibrils in vitro. , 1993, Biological chemistry Hoppe-Seyler.

[10]  J. Richardson,et al.  Natural β-sheet proteins use negative design to avoid edge-to-edge aggregation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[11]  V. Uversky,et al.  Effect of Association State and Conformational Stability on the Kinetics of Immunoglobulin Light Chain Amyloid Fibril Formation at Physiological pH* , 2002, The Journal of Biological Chemistry.

[12]  C. Blake,et al.  From the globular to the fibrous state: protein structure and structural conversion in amyloid formation , 1998, Quarterly Reviews of Biophysics.

[13]  C. Yu,et al.  Amyloid-like Fibril Formation in an All β-Barrel Protein Involves the Formation of Partially Structured Intermediate(s)* , 2002, The Journal of Biological Chemistry.

[14]  Berk Hess,et al.  LINCS: A linear constraint solver for molecular simulations , 1997, J. Comput. Chem..

[15]  M. Hurle,et al.  A role for destabilizing amino acid replacements in light-chain amyloidosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[16]  F. Stevens,et al.  Four structural risk factors identify most fibril-forming kappa light chains , 2000, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[17]  B. Iványi Frequency of light chain deposition nephropathy relative to renal amyloidosis and Bence Jones cast nephropathy in a necropsy study of patients with myeloma. , 1990, Archives of pathology & laboratory medicine.

[18]  M. Schiffer,et al.  Protein conformation and disease: pathological consequences of analogous mutations in homologous proteins. , 2000, Biochemistry.

[19]  R. Wetzel Domain stability in immunoglobulin light chain deposition disorders. , 1997, Advances in protein chemistry.

[20]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[21]  D. van der Spoel,et al.  GROMACS: A message-passing parallel molecular dynamics implementation , 1995 .

[22]  Berk Hess,et al.  LINCS: A linear constraint solver for molecular simulations , 1997 .

[23]  M. Hoshino,et al.  Mapping the core of the beta(2)-microglobulin amyloid fibril by H/D exchange. , 2002, Nature structural biology.

[24]  R. Huber,et al.  The molecular structure of a dimer composed of the variable portions of the Bence-Jones protein REI refined at 2.0-A resolution. , 1975, Biochemistry.

[25]  G Vriend,et al.  WHAT IF: a molecular modeling and drug design program. , 1990, Journal of molecular graphics.

[26]  M. Hoshino,et al.  Mapping the core of the β2-microglobulin amyloid fibril by H/D exchange , 2002, Nature Structural Biology.

[27]  Takashi,et al.  Structural relationship of κ‐type light chains with AL amyloidosis: multiple deletions found in a VκIV protein , 1999 .

[28]  C. Blake,et al.  The structure of amyloid fibrils by electron microscopy and X-ray diffraction. , 1997, Advances in protein chemistry.

[29]  A G Murzin,et al.  SCOP: a structural classification of proteins database for the investigation of sequences and structures. , 1995, Journal of molecular biology.

[30]  W. Kabsch,et al.  Dictionary of protein secondary structure: Pattern recognition of hydrogen‐bonded and geometrical features , 1983, Biopolymers.

[31]  R. Wetzel,et al.  Specificity of abnormal assembly in immunoglobulin light chain deposition disease and amyloidosis. , 1996, Journal of molecular biology.

[32]  S. Radford,et al.  Structural properties of an amyloid precursor of β2-microglobulin , 2002, Nature Structural Biology.